The effect of the erythropoietin resistance index on brain hemorrhage and infarction risk in maintenance hemodialysis patients: a retrospective cohort study. [PDF]
Liu M +6 more
europepmc +1 more source
Global research trends in renal anemia: a multidimensional bibliometric study. [PDF]
Niu Y, Wang Y, Huo C, Fang Y.
europepmc +1 more source
Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial. [PDF]
Jia Q +19 more
europepmc +1 more source
Association between serum hepcidin-25 levels and hyporesponsiveness to erythropoiesis-stimulating agents in Japanese patients receiving hemodialysis: a cross-sectional study. [PDF]
Fujikawa R, Nagano N, Mitobe Y, Ito K.
europepmc +1 more source
Hepatic modulation of apelin and galectin-3 by darbepoetin-alpha in Dexamethasone induced insulin-resistant rats. [PDF]
Yildiz HT, Turk A, Katirci E, Kalkan KT.
europepmc +1 more source
Erythropoiesis-Stimulating Agents and Development of Cancer Among Patients Receiving Dialysis.
Kim JY, Lee JK, Chang TI, Kim HW.
europepmc +1 more source
Quantitative determination of iron (III) in polymaltose haematinic formulations on the Ghanaian market. [PDF]
Okwampah R +7 more
europepmc +1 more source
Management of PErioperative Anemia in EmeRgency Laparotomy Patients (PEARL Study). [PDF]
Lakshmanan V +7 more
europepmc +1 more source
Tibial Lead Levels and Erythropoiesis Stimulating Agent Dosing among 75 Patients with End-Stage Kidney Disease. [PDF]
Nissaisorakarn V, Specht A, Danziger J.
europepmc +1 more source
Low sirtuin-1 levels are linked to erythropoietin resistance in hemodialysis patients. [PDF]
Hekimgil E, Gul CB.
europepmc +1 more source

